The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...
An 18-year-old’s long-standing snoring and nasal congestion were brushed off as allergies, until the doctor revealed a nasal ...
A new study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), which include popular weight loss drugs like ...
The results of a pilot study suggest that long-term exposure to higher pollen levels leads to worse symptoms and quality of ...
From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results